FNOAI — MANKIND

MANKIND MANKIND PHARMA LIMITED

Overview Price & levels F&O Financials & peers Companyas of Thu 15 Oct 15:30

MANKIND PHARMA LIMITED — on this desk since 30 May 2025.

Results meeting in 10 days Mon 26 Oct 2026, as the company announced it to NSE

2,347.60

adjusted for splits, bonuses and dividends

Day

0.54%

Against NIFTY, month

3.5%

its return less the index's, same sessions

Against NIFTY, quarter

-3.3%

Typical day

2.65%

its own 20-session range

Traded value

147.3 cr

20-session average

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_state · commit 4ccbd35

Where it stands

as of Thu 15 Oct 15:30

inside its recent range, back inside the last advance.

Movement: mixed
Sessions measured: 279
Delivered: 61.4%

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_structure · commit 4ccbd35

Its own last sixty sessions

as of Thu 15 Oct 15:30

Traded value sat inside its own last 60 sessions.

The session’s range sat inside its own last 60.

Each is a rank against this stock's own history, not a comparison with any other stock and not a number from a distribution.

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_state · commit 4ccbd35

What changed

as of Thu 15 Oct 15:30

15 Oct 2026acquisition, merger or stake sale
the filing states no amount.
Sources
Filed
NSE · 2026-10-15 19:33 IST
Document
raw/nse_announcement_docs/2026-10-15/3789db4ed4f6_3789db4ed4f6_MANKIND1_15102026192506_Outcomefinalsd.pdf · SHA-256 3789db4ed4f6
Read from
“a majority stake (i.e., 70%)” · page 1 · characters 990–1018
Read by
claude-haiku-4-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
15 Oct 2026acquisition, merger or stake sale
the filing states no amount.
MANKIND filed an acquisition, merger or stake sale.
Sources
Filed
NSE · 2026-10-15 19:28 IST
Document
raw/nse_announcement_docs/2026-10-15/3789db4ed4f6_3789db4ed4f6_MANKIND1_15102026192506_Outcomefinalsd.pdf · SHA-256 3789db4ed4f6
Read from
“a majority stake (i.e., 70%) in Armed Cell Therapeutics B.V.” · page 1 · characters 990–1050
Read by
claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed

What such filings have been followed by

as of Thu 15 Oct 15:30

No filing of this stock in the last month has a record yet: its size is not measured, it states no amount, or it came on the same session as another.

Its filings, newest first

as of Thu 15 Oct 15:30

15 Oct 2026acquisition, merger or stake sale
the filing states no amount.
15 Oct 2026acquisition, merger or stake sale
the filing states no amount.
13 Aug 2026acquisition, merger or stake sale
the filing states no amount.
30 Jul 2026results
the move was 0.5-1x what the options priced.
27 Jul 2026acquisition, merger or stake sale₹49 crore
<1% of the company's market value.
11 Jul 2026acquisition, merger or stake sale
the filing states no amount.
2 Jun 2026acquisition, merger or stake sale
the filing states no amount.
19 May 2026results
the move was 0.5-1x what the options priced.
12 May 2026a rating keptICRA AA+
reaffirmed.
22 Apr 2026a rating assigned₹1,000 crore
reaffirmed.
13 Apr 2026acquisition, merger or stake sale
the filing states no amount.
18 Mar 2026acquisition, merger or stake sale
the filing states no amount.
24 Feb 2026a rating keptICRA AA+/Stable
reaffirmed.
3 Feb 2026results
the move was 0.5-1x what the options priced.
16 Jan 2026a rating withdrawn
reaffirmed.
13 Nov 2025a rating withdrawn₹3,500 crore
reaffirmed.
6 Nov 2025results
the move was <0.5x what the options priced.
29 Oct 2025a rating withdrawn
reaffirmed.
10 Oct 2025acquisition, merger or stake sale₹797 crore
<1% of the company's market value.
31 Jul 2025acquisition, merger or stake sale
the filing states no amount; filed on the same session as another filing.

Every kind of filing, across the market

What has followed each state

as of Thu 15 Oct 15:30

When it stood	After	Closed higher	Of
inside its recent rangenow	3 sessions	36	83
inside its recent rangenow	5 sessions	28	81
inside its recent rangenow	10 sessions	21	77
inside its recent rangenow	21 sessions	14	77
lower highs and lower lows	3 sessions	52	96
lower highs and lower lows	5 sessions	53	96
lower highs and lower lows	10 sessions	56	95
lower highs and lower lows	21 sessions	50	84
not enough history to say	3 sessions	23	35
not enough history to say	5 sessions	21	35
not enough history to say	10 sessions	20	35
not enough history to say	21 sessions	27	35
higher highs and higher lows	3 sessions	55	126
higher highs and higher lows	5 sessions	56	126
higher highs and higher lows	10 sessions	56	126
higher highs and higher lows	21 sessions	52	126

Counts from this stock's own record: on how many of the days it stood in that state the close that many sessions later was higher. A greyed row has fewer than 30 such days, too few to read as a tendency, and its counts are printed anyway. A day whose later session has not arrived is not counted.

Sources

Source: NSE's daily cash-market bhavcopy
Session: Thu 15 Oct 2026
File: raw/nse_archive_cash/2026-10-15/3d1c7039e2c7_BhavCopy_NSE_CM_0_0_0_20261015_F_0000.csv.zip · SHA-256 3d1c7039e2c7
Run: 53e277ce-9f3a-4528-8ecb-d4f173c110e7 · stock_structure · commit 4ccbd35